Table 2 Patient demographics and selected initial clinical examination findings within the test dataset.
Cohort characteristics | n = 55 |
|---|---|
Demographics | |
Females, number (percentage) | 33 (60%) |
Age (years) | 11.8 (SD 4.1) |
Number of patients with TMJ involvement Drugs | 7 (12.7%) |
No medication | 10 (18.2%) |
NSAID | 4 (7.3%) |
MTX | 13 (23.6%) |
Anti-TNF-alpha (bDMARDs) | 7 (12.7%) |
NSAID + MTX | 6 (10.9%) |
MTX + Anti-TNF-alpha | 11 (20.0%) |
Other combinations | 4 (7.3%) |
Clinical examination features | |
Orofacial symptoms | |
TMJ pain during movement | 7 (12.7%) |
TMJ pain during opening | 5 (9.1%) |
TMJ pain during palpation | 8 (14.6%) |
Reduced chewing function | 5 (9.1%) |
Clinical findings | |
Crepitation present | 9 (16.4%) |
Overbite (mean in mm) | 2.4 (SD 1.8) |
Overjet (mean in mm) | 3.3 (SD 2.2) |
Asymmetry | |
Face | 18 (32.7%) |
Occlusal plane | 7 (12.7%) |
Profile | |
Convex | 43 (78.2%) |
Lower facial height decreased | 4 (7.3%) |
Mandibular retrognathism | 3 (5.5%) |
